Sarepta Therapeutics Inc.
About Sarepta Therapeutics Inc.
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Convertible Senior Notes Exchange T: - FT: Convertible Senior Notes Exchange |
A: 291400000 MR: - FA: approximately $291.4 million FAN: 291400000 |
D: 2025-12-11 FD: 2025-12-11 |
- |
| 2 |
RT: Debt T: - FT: Debt |
A: 600000000 MR: - FA: $600 million FAN: 600000000 |
D: 2025-02-14 FD: 2025-02-14 |
9 investors |
Growth Metrics
Team & Leadership
Wendy Erler
Senior Vice President, Patient Affairs
Nicole LaMarca
Senior Director, Patient Affairs
Rachita Chaudhury-Floros
Associate Director, Patient Affairs
Monique Dabbous
Associate Director, Patient Affairs
Katherine Sinars
Senior Specialist, Patient Affairs
Rachael Titus
Senior Specialist, Patient Affairs
Recent News
Sarepta Therapeutics Inc. Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- sarepta.com
- Industries
- Biotechnology / Biopharmaceutical
- Company Size
- ~580 employees (est.)
- Locations
-
Los Angeles, CA
United States
Radnor, PA, United States +5 more
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro